Evaluation of the Immature Reticulocyte Fraction (IRF) and Immature Platelet Fraction (IPF) for Differentiation of Fever Symptoms in Patients with Dengue Fever and with Influenza

Authors

  • ๋Jinapat Phucharoentum Department of Medical Technology, Taksin Hospital, Medical Service Department Bangkok Metropolitan Administration, Bangkok, Thailand
  • Pilaiwan Siripurkpong Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Rangsit Campus, Pathum Thani Province, Thailand

Keywords:

Immature reticulocyte fraction (IRF) , Immature platelet fraction (IPF), Dengue fever

Abstract

Dengue fever is caused by dengue virus, transmitted by female mosquitoes. One of the pathological mechanisms following viral infection is bone marrow suppression, which perturbs erythropoiesis and thrombopoiesis. The immature reticulocyte fraction (IRF) and the immature platelet fraction (IPF) indicate the functions of bone marrow. IRF is commonly used to monitor bone marrow transplantation patients and anemic individuals, while IPF can be used to evaluate platelet recovery following platelet transfusion. In this study, collective data from 122 subjects aged between 18-34 years old were divided into control, influenza, and dengue fever groups. Moreover, patients with dengue fever were categorized into the febrile, critical and recovery phases. General characteristics such as age, body temperature, blood pressure and pulse as well as all complete blood count (CBC) parameters were collected and statistically analyzed. The average IRF and IPF of control, influenza and dengue fever groups were 9.65%, 8.33%, 11.87% and 1.77%, 2.46%, 4.82%, respectively. There were significant differences among these three groups for IPF values (p < 0.001), but not for IRF values. For dengue fever with febrile, critical and recovery phases, the averages IRF were 10.96%, 10.66% and 13.99% and the average IPF were 3.01%, 7.95% and 3.50%, respectively. There were significant differences among the three groups for IPF values (p = 0.001), but not for IRF values. For comparison of IRF and IPF values in patients with fever (≥ 37.5°C), IRF was not significantly different (p = 0.970) between influenza and dengue fever groups whereas IPF in dengue fever group (5.48%) was significantly higher than that of the influenza group (2.46%) (p < 0.001). To evaluate the efficiency of IPF, ROC curve analysis was used, and the results showed that the AUC of the IPF was 0.777 (95% CI 0.668-0.886). At the cut-off value of 2.15%, the sensitivity and specificity of IPF were 85.7% and 50.0%, respectively. These suggest that IPF can be used in combination with other parameters along with patient symptoms for screening dengue fever from influenza for early diagnosis and optimal treatment.

References

Siriyasatien P, Phumee A, et. al. Analysis of significant factors for dengue fever incidence prediction. BMC Bioinform. 2016;17(1):1-9.

Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res. 2016, Article ID 6803098,14 pages. Available from: http://dx.doi.org/10.1155/2016/6803098.

Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annual Rev Immunol. 2011;29:587-619.

Department of disease control, Minitry of public health. Situation of dengue fever in the 23rd week, 2019. Office of the permanent secretary Ministry of public health 2019. (In Thai)

Kanoktip T, Sukathida U, Chantapong W. Dengue fever, dengue hemorrhagic fever: virology, immunopathogenesis, diagnosis, vaccine, prevention and control. 2006. Available from: https://repository.li.mahidol.ac.th/handle/123456789/57117 (In Thai)

La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillières Clin Haematol. 1995;8(1):249-70.

Butthep P. Advanced technology in automated blood cell analyzer. Hemato Transfus Med. 2009;19 (1):13-9.

Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab hematol. 2009;31(3):277-97.

Sindhu R, Behera S, Mishra D. Role of immature reticulocyte fraction in evaluation of aplastic anemia in cases of pancytopenia. Indian J Basic Appl Med Res. 2016;5(3):619-24.

Yesmin M, Nesa A, Sultana T, et. al. Haematopoietic recovery on induction therapy in acute lymphoblastic leukaemia by automated Reticulocyte Analysis. Bangladesh J Patho. 2011;26(1):10-3.

Oehadian A, Vidyaniati P, Candra JM, et. al. Erythropoiesis differences in various clinical phases of dengue fever using immature reticulocyte fraction parameter. IJIHS. 2021;9(1):7-12.

Briggs C, Hart D, Kunka S, et. al. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med. 2006;16(2):101-9.

Dadu T, Sehgal K, Joshi M, et. al. Evaluation of the immature platelet fraction as an indicator of platelet recovery in dengue patients. Int J Lab hemato. 2014;36(5):499-504.

Tanaka Y. Plasmacytoid lymphocytes: a diagnostic clue for dengue fever. Internal Med. 2018;57(19):2917.

Department of medical services, Ministry of public health. Guidelines for diagnosis and treatment of dengue hemorrhagic fever in central and general hospitals, Bangkok: The agricultural co-operative federation of Thailand, Ltd; 2005;1:8-33.

Department of medical services, Ministry of public health. Clinical practice guideline for influenza, 3rd reu. ed:2011.

Ramathibodi hospital, Mahidol university. Follow up pediatric patients treatment. Guidelines for caring pediatric patients after bone marrow transplantation. Bangkok: Swichan Press Ltd., 2004:16.

Naz A, Mukry SN, Shaikh MR, et. al. Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura. Paki J Med Sci. 2016;32(3):575-9.

Khormi HM, Kumar L. Modeling dengue fever risk based on socioeconomic parameters, nationality and age groups: GIS and remote sensing based case study. Sci Total Environ 2011;409(22):4713-9.

Laoprasopwattana K. The theory into practice of dengue virus infection. Songkla: Faculty of medicine, Prince of Songkla university;2017.

World Health Organization. Guidelines for diagnosis, treatment, prevention and control. 2009.

Jampangern W, Vongthoung K, Jittmittraphap A, et. al. Characterization of atypical lymphocytes and immunophenotypes of lymphocytes in patients with dengue virus infection. Asian Pac J Allergy Immuno. 2007;25(1):27.

Chuansumrit A, Apiwattanakul N, Sirachainan N, et. al. The use of immature platelet fraction to predict time to platelet recovery in patients with dengue infection. Paediatr and Int Child Health. 2020;40(2):124-8.

Madhusudan S, Prabhavathi R, Ranganath K, et. al. Study of immature platelet fraction as a predictor of platelet recovery in pediatric dengue patients. J Cardiovas Dis Res. 2022;13(05):1655-9.

Lin CF, Lei HY, Liu CC, et. al. Generation of IgM anti‐platelet autoantibody in dengue patients. Med Virol. 2001;63(2):143-9.

Sun DS, King CC, Huang HS, et. al. Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice. Thromb and Haemost. 2007;5(11):2291-9.

Hottz ED, Oliveira MF, Nunes PC, et. al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. Thromb and Haemost. 2013;11(5):951-62.

Azeredo ELd, Monteiro RQ, de-Oliveira Pinto LM. Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediators Inflamm. 2015, Article ID 313842,16 pages. Available from: http://dx.doi.org/10.115/2015/313842

Clark KB, Noisakran S, Onlamoon N, et. al. Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. Plos One. 2012;7(12):e52902.

World Health Organization. Guidelines for the treatment of malaria, Switzerland, 2006.

World Health Organization. Integrated management of childhood illness. 2008.

Looi KW, Matsui Y, Kono M, et. al. Evaluation of immature platelet fraction as a marker of dengue fever progression. Intern J of Infect Dis. 2021;110:187-94.

Yasuda I, Saito N, Suzuki M, et. al. Unique characteristics of new complete blood count parameters, the immature platelet fraction and the immature platelet fraction count, in dengue patients. Plos One. 2021;16(11):e0258936.

Downloads

Published

2023-08-31 — Updated on 2023-09-09

How to Cite

1.
Phucharoentum ๋, Siripurkpong P. Evaluation of the Immature Reticulocyte Fraction (IRF) and Immature Platelet Fraction (IPF) for Differentiation of Fever Symptoms in Patients with Dengue Fever and with Influenza. วารสารเทคนิคการแพทย์ [internet]. 2023 Sep. 9 [cited 2026 Jan. 24];51(2):8584-600. available from: https://he01.tci-thaijo.org/index.php/jmt-amtt/article/view/262544

Issue

Section

Original Articles